Cargando…
Multi-Omics Signatures Identification for LUAD Prognosis Prediction Model Based on the Integrative Analysis of Immune and Hypoxia Signals
Lung adenocarcinoma (LUAD) is the most common histological subtype of lung cancer with heterogeneous outcomes and diverse therapeutic responses. However, the understanding of the potential mechanism behind LUAD initiation and progression remains limited. Increasing evidence shows the clinical signif...
Autores principales: | Lou, Yuqing, Shi, Qin, Zhang, Yanwei, Qi, Ying, Zhang, Wei, Wang, Huimin, Lu, Jun, Han, Baohui, Zhong, Hua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8960258/ https://www.ncbi.nlm.nih.gov/pubmed/35359451 http://dx.doi.org/10.3389/fcell.2022.840466 |
Ejemplares similares
-
Multi-Omics Data Integration Analysis of an Immune-Related Gene Signature in LGG Patients With Epilepsy
por: Cheng, Quan, et al.
Publicado: (2021) -
Multi-Omics Prognostic Signatures Based on Lipid Metabolism for Colorectal Cancer
por: Sun, YuanLin, et al.
Publicado: (2022) -
Multi-Omics Analysis of Anlotinib in Pancreatic Cancer and Development of an Anlotinib-Related Prognostic Signature
por: Zhang, Xi, et al.
Publicado: (2021) -
Multi-Omics Integration to Reveal the Mechanism of Hepatotoxicity Induced by Dictamnine
por: Tu, Can, et al.
Publicado: (2021) -
The hypoxia-related signature predicts prognosis, pyroptosis and drug sensitivity of osteosarcoma
por: Hu, Lin, et al.
Publicado: (2022)